Skip to content

Olema Oncology, Inc.

OLMA· NasdaqCore metricsCIK 1750284

Pharmaceutical preparations553 peers

Last sale
Nov 12, 2026 · -6.47%
Market cap
$658.80M
87.61M shares
Filings
566
—
—
—
-$73.60M
Q3 2026N/M FY25 yoy
-$77.53M
Q3 2026N/M FY25 yoy
-$140.12M
Q3 2026derivedN/M FY24 yoy
-$0.73
Q3 2026N/M FY25 yoy
$47.52M
Q3 2026−65.4% FY25 yoy
$658.80M
—
—
1.8×
—
—

FY2025 figures · derived

Price

$7.528.18%$0.67past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Research And Development

$157.70MFY 2025
$157.70M0FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$157,697,000reported
FY 20242024-12-31$124,517,000reported
FY 20232023-12-31$86,140,000reported
FY 20222022-12-31$82,274,000reported
FY 20212021-12-31$51,100,000reported
FY 20202020-12-31$13,704,000reported
FY 20192019-12-31$3,920,000reported

Pharmaceutical preparations

Olema Oncology, Inc. is the 169th largest of the 554 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Olema Oncology, Inc. · CIK 1750284 · Engraved from SEC EDGAR